⌘K

Login Start Free

Home/Filings/4/0001822629-24-000010

4//SEC Filing

Lalwani Nikhil 4

Accession 0001822629-24-000010

CIK 0001023024other

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 5:02 PM ET

Size

5.1 KB

Accession

0001822629-24-000010

Insider Transaction Report

Form 4

Period: 2024-05-14

ANI PHARMACEUTICALS INCANIP

DirectorPRESIDENT & CEO

Transactions

Sale
Common Stock
2024-05-14$66.10/sh−16,669$1,101,821→ 377,505 total

Footnotes (1)

[F1]The shares were sold in multiple trades at prices ranging from $65.67 to $67.56. The price reported above reflects the weighted average sales price.

Documents

1 file

4
wk-form4_1715893316.xmlPrimary
FORM 4

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001822629

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 5:02 PM ET
Size: 5.1 KB

View on SEC.gov